Cargando…
Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes
Hypereosinophilic syndrome, which is characterized by eosinophilia in the peripheral blood, often causes various organ disorders. Charcot-Leyden crystals are recognized features of various diseases, such as parasite infection and asthma, and are known to be classic hallmarks of eosinophilic inflamma...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402945/ https://www.ncbi.nlm.nih.gov/pubmed/32789109 http://dx.doi.org/10.5415/apallergy.2020.10.e24 |
_version_ | 1783566860151685120 |
---|---|
author | Takeda, Masahide Ueki, Shigeharu Yamamoto, Yohei Nara, Miho Fukuchi, Mineyo Nakayama, Katsutoshi Omori, Yasufumi Takahashi, Naoto Hirokawa, Makoto |
author_facet | Takeda, Masahide Ueki, Shigeharu Yamamoto, Yohei Nara, Miho Fukuchi, Mineyo Nakayama, Katsutoshi Omori, Yasufumi Takahashi, Naoto Hirokawa, Makoto |
author_sort | Takeda, Masahide |
collection | PubMed |
description | Hypereosinophilic syndrome, which is characterized by eosinophilia in the peripheral blood, often causes various organ disorders. Charcot-Leyden crystals are recognized features of various diseases, such as parasite infection and asthma, and are known to be classic hallmarks of eosinophilic inflammation. Our recent study revealed the mechanism of Charcot-Leyden crystal formation (i.e., galectin-10 crystallization), namely the involvement of eosinophil extracellular trap cell death, a nonapoptotic cell death. Here we report an autopsy case of a 57-year-old man who had died of hypereosinophilic syndrome. We found numerous eosinophil extracellular trap cell death-associated Charcot-Leyden crystals in the spleen and lymph nodes. Observation of abdominal lymph nodes by electron microscopy revealed eosinophil extracellular traps and free extracellular granules, which are characteristic of typical eosinophil extracellular trap cell death. In this case, we observed various sizes of Charcot-Leyden crystals that were stained with anti-galectin-10 immunofluorescent staining. Further studies are required to understand the pathophysiological roles of Charcot-Leyden crystals and these may lead to the development of novel therapeutic modalities for severe eosinophilic inflammation. |
format | Online Article Text |
id | pubmed-7402945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Asia Pacific Association of Allergy, Asthma and Clinical Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-74029452020-08-11 Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes Takeda, Masahide Ueki, Shigeharu Yamamoto, Yohei Nara, Miho Fukuchi, Mineyo Nakayama, Katsutoshi Omori, Yasufumi Takahashi, Naoto Hirokawa, Makoto Asia Pac Allergy Case Report Hypereosinophilic syndrome, which is characterized by eosinophilia in the peripheral blood, often causes various organ disorders. Charcot-Leyden crystals are recognized features of various diseases, such as parasite infection and asthma, and are known to be classic hallmarks of eosinophilic inflammation. Our recent study revealed the mechanism of Charcot-Leyden crystal formation (i.e., galectin-10 crystallization), namely the involvement of eosinophil extracellular trap cell death, a nonapoptotic cell death. Here we report an autopsy case of a 57-year-old man who had died of hypereosinophilic syndrome. We found numerous eosinophil extracellular trap cell death-associated Charcot-Leyden crystals in the spleen and lymph nodes. Observation of abdominal lymph nodes by electron microscopy revealed eosinophil extracellular traps and free extracellular granules, which are characteristic of typical eosinophil extracellular trap cell death. In this case, we observed various sizes of Charcot-Leyden crystals that were stained with anti-galectin-10 immunofluorescent staining. Further studies are required to understand the pathophysiological roles of Charcot-Leyden crystals and these may lead to the development of novel therapeutic modalities for severe eosinophilic inflammation. Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2020-07-08 /pmc/articles/PMC7402945/ /pubmed/32789109 http://dx.doi.org/10.5415/apallergy.2020.10.e24 Text en Copyright © 2020. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Takeda, Masahide Ueki, Shigeharu Yamamoto, Yohei Nara, Miho Fukuchi, Mineyo Nakayama, Katsutoshi Omori, Yasufumi Takahashi, Naoto Hirokawa, Makoto Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes |
title | Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes |
title_full | Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes |
title_fullStr | Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes |
title_full_unstemmed | Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes |
title_short | Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes |
title_sort | hypereosinophilic syndrome with abundant charcot-leyden crystals in spleen and lymph nodes |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402945/ https://www.ncbi.nlm.nih.gov/pubmed/32789109 http://dx.doi.org/10.5415/apallergy.2020.10.e24 |
work_keys_str_mv | AT takedamasahide hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT uekishigeharu hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT yamamotoyohei hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT naramiho hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT fukuchimineyo hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT nakayamakatsutoshi hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT omoriyasufumi hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT takahashinaoto hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes AT hirokawamakoto hypereosinophilicsyndromewithabundantcharcotleydencrystalsinspleenandlymphnodes |